Asset Details
- Identifier:
- JCH_4450_f1
- Description:
- Isradipine‐controlled release (CR) substitution study trial design. Following a 6‐month run‐in period, amlodipine‐treated patients were converted to an equivalent dose of isradipine‐CR for 6 weeks. After 6 weeks of isradipine‐CR treatment, patients resumed therapy with amlodipine for an additional 6 weeks. BP=blood pressure
- License:
- Rights Managed
- Rights Holder:
- John Wiley & Sons, Inc.
- License Rights Holder:
- Asset Type:
- Image
- Asset Subtype:
- Figure
- Image Orientation:
- Landscape
- Image Dimensions:
- 1000 x 500
- Image File Size:
- 86.8 KB
- Creator:
- Michael Ganz, MD, Rasoul Mokabberi, MD, Domenic A. Sica, MD
- Credit:
- Ganz, M., Mokabberi, R., & Sica, D. A. (2005). Comparison of Blood Pressure Control With Amlodipine and Controlled‐Release Isradipine: An Open‐Label, Drug Substitution Study. The Journal of Clinical Hypertension, 7 27-31. https://doi.org/10.1111/j.1524-6175.2005.04450.x.
- Collection:
- Keywords:
- Restrictions:
- Property Release:
- No
- Model Release:
- No
- Purchasable:
- Yes
- Sensitive Materials:
- No
- Article Title:
- Comparison of Blood Pressure Control With Amlodipine and Controlled‐Release Isradipine: An Open‐Label, Drug Substitution Study
- Article Authors:
- Michael Ganz, MD, Rasoul Mokabberi, MD, Domenic A. Sica, MD
- Article Copyright Year:
- 2005
- Publication Title:
- The Journal of Clinical Hypertension
- Publication Volume:
- 7
- Publication Issue:
- Publication Date:
- 04/01/2005
- DOI:
- https://doi.org/10.1111/j.1524-6175.2005.04450.x
Click on image to enlarge
